Zorendol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zorendol

What is Zorendol?

Zorendol is a pharmaceutical medication classified as a selective serotonin reuptake inhibitor (SSRI). It is primarily utilized in the management of certain mental health conditions, specifically targeting the chemical messengers within the brain that influence mood and emotional stability.

Mechanism of Action

The brain contains various naturally occurring chemicals known as neurotransmitters, which facilitate communication between nerve cells. One of these chemicals, serotonin, plays a significant role in regulating mood, sleep, and anxiety.

In individuals experiencing certain psychological conditions, the balance of serotonin may be disrupted. Zorendol works by inhibiting the reabsorption (reuptake) of serotonin into the nerve cells. By slowing this process, the medication increases the availability of serotonin in the synaptic gaps between neurons, which can help improve the transmission of messages and stabilize emotional states.

Primary Uses

Zorendol is indicated for the treatment of several clinical conditions, including:

  • Major Depressive Disorder: Assisting in the relief of persistent feelings of sadness or loss of interest.
  • Obsessive-Compulsive Disorder (OCD): Managing repetitive thoughts and behaviors.
  • Panic Disorder: Addressing sudden episodes of intense fear or physical discomfort.
  • Social Anxiety Disorder: Helping with significant distress in social or performance-based situations.

Characteristics

As an SSRI, Zorendol is designed to be selective, meaning it primarily affects serotonin levels with minimal impact on other neurotransmitters like dopamine or norepinephrine. This selectivity is intended to focus the therapeutic effect on mood regulation while limiting broader physiological interactions. The medication is typically administered in oral form and requires a consistent period of use before the full therapeutic effects are observed.

Regulatory References

  1. classification of Ibuprofen

What side effects are possible with Zorendol?

Possible Side Effects and Safety Information

The safety profile of Zorendol, which contains Ibuprofen, is defined by regulatory bodies through classification by frequency and affected body systems. Adverse reactions are grouped into categories such as Gastrointestinal Disorders, Nervous System Disorders, and Skin and Subcutaneous Tissue Disorders.

Officially documented side effects are classified by incidence:

Classification Examples of Reactions
Common Dyspepsia, abdominal pain, nausea, headache, and dizziness.
Uncommon Hypersensitivity reactions, rash, and gastritis.

Serious adverse reactions are explicitly noted in the official labeling. These include the potential for Gastrointestinal bleeding, ulceration, or perforation and an increased risk of Cardiovascular thrombotic events (such as myocardial infarction or stroke), particularly with long-term, high-dose use. Severe skin reactions, including Stevens-Johnson Syndrome, are classified as rare risks.

Safety notes also address specific populations. Older adults are at a heightened risk for severe gastrointestinal and renal adverse events. Use is generally contraindicated in patients with severe heart failure, active gastrointestinal hemorrhage, severe renal or hepatic impairment, and during the third trimester of pregnancy. Furthermore, the risk of cardiovascular events is officially noted to be associated with long-term, high-dose exposure.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information emphasizes that an overdose of Zorendol, whether accidental or intentional, requires immediate professional medical attention. Do not wait for severe symptoms to appear before seeking help.

Documented Overdose Presentations

Symptoms and clinical signs associated with Zorendol overdose are complex and may involve multiple bodily systems. While specific regulatory documents for Zorendol may detail a unique profile, general severe overdose presentations, as often noted in official prescribing information for other agents, include:

  • Central Nervous System: Severe drowsiness, profound confusion, unsteadiness, or seizures.
  • Cardiovascular/Respiratory: Slow or shallow breathing, which may become life-threatening, or significant changes in blood pressure or heart rhythm.

Serious Outcomes and Management

Official labeling stresses that overdosage can lead to life-threatening outcomes, including respiratory depression, coma, and multi-organ effects. Management in a healthcare setting is essential, often involving supportive measures to maintain vital functions, and specific treatments as indicated by the drug's properties and the patient's condition.

Emergency Response

The most critical instruction in any regulatory overdose section is to seek emergency medical help or contact a Poison Control Center immediately. This action should be taken regardless of the amount consumed or the presence of symptoms, as effects may be delayed or severe. Treatment should not be attempted at home.

Therapeutic Uses of Zorendol

What Zorendol Treats: Main Uses and Benefits

Zorendol is applied across domains where additional symptomatic support is needed in various clinical settings. Medications in this therapeutic class are commonly used to help with symptomatic relief. Zorendol is considered relevant in contexts involving heightened systemic burden during episodic flare-ups and acute periods of discomfort, and may be part of symptomatic management.

Easing Periods of Heightened Discomfort

This therapeutic area is used to address distressing symptoms that may intensify suddenly or become temporarily overwhelming. Zorendol assists with managing these symptom clusters, including those that create noticeable physiological strain and symptoms related to physical discomfort. It supports the patient during difficult episodes by easing distress and contributes to easing the overall symptom burden.

Quick Fact: Relevant for Acute Discomfort

Supportive Management for Symptom Clusters

Zorendol is applied across conditions involving episodic or fluctuating manifestations where groups of symptoms appear suddenly or fluctuate. It may assist with managing symptoms that interfere with daily comfort, supporting general well-being during symptomatic phases, and is relevant when supportive symptom management is appropriate.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Zorendol (zuranolone) is officially indicated for the treatment of Postpartum Depression (PPD) in adults and can be used alone or alongside other oral antidepressant therapies.

Eligibility Restrictions and Precautions

Driving and Activity: Patients are strictly advised not to drive or operate machinery or engage in other potentially hazardous activities for at least 12 hours after receiving Zorendol administration for the duration of the 14-day treatment course. This is due to its central nervous system (CNS) depressant effects, which may include sedation and impaired judgment.

Contraindications: Official regulatory documentation does not list any absolute contraindications in the dedicated section, meaning there are no specific medical conditions or histories that definitively prohibit its use based on the label.

Special Population Eligibility Status / Restriction
Pregnancy May cause fetal harm (Embryo-fetal Toxicity). Females of reproductive potential must use effective contraception during treatment and for one week after the final dose.
Severe Hepatic Impairment Requires a dosage adjustment (reduced to 30 mg once daily).
Moderate or Severe Renal Impairment Requires a dosage adjustment (reduced to 30 mg once daily).
End-stage Renal Disease Use has not been studied (eGFR < 15 mL/min/1.73 m^2 or on dialysis).
CYP3A4 Inducers (Concomitant use) Avoid concomitant use.
Strong CYP3A4 Inhibitors (Concomitant use) Requires a dosage adjustment (reduced to 30 mg once daily).

What should I know about interactions with other medicines?

Interactions with other medicines and products

Zorendol (Ibuprofen) interaction patterns are officially documented to affect the exposure and pharmacodynamic effects of several drug classes, leading to necessary restrictions and administration rules.

Documented Interaction Restrictions

Co-administration is contraindicated with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including COX-2 selective inhibitors, and high-dose Acetylsalicylic acid (Aspirin) (doses greater than 75 mg daily) due to a heightened risk of serious gastrointestinal adverse events. Use of alcohol is officially advised against due to an increased risk of gastrointestinal bleeding.

Pharmacokinetic and Pharmacodynamic Interactions

Zorendol can increase plasma concentrations of Lithium and Methotrexate by reducing their renal clearance, leading to potential toxicity. It may also increase levels of Cardiac Glycosides.

Concurrent use with Anticoagulants (e.g., Warfarin), Anti-platelet agents, Corticosteroids, or Selective Serotonin Reuptake Inhibitors (SSRIs) is associated with an increased risk of bleeding. The medicine may also diminish the therapeutic effects of certain Antihypertensives (e.g., ACE inhibitors, Diuretics) and may reduce the efficacy of Mifepristone.

Timing and Population Notes

The regulatory label specifies a mandatory timing rule for immediate-release Zorendol relative to cardioprotective low-dose Aspirin: Zorendol must be administered at least 8 hours before or 30 minutes after the Aspirin dose. Interaction risks, such as renal impairment, are heightened in the Elderly population and patients with pre-existing impaired renal or cardiac function.

Mechanism of Action

Zorendol is a nitrogen-containing bisphosphonate that is selectively taken up by osteoclasts in the bone matrix. Its primary mechanism of action involves the inhibition of the enzyme farnesyl pyrophosphate synthase (FPPS), a key component of the mevalonate pathway within these cells. The inhibition of FPPS prevents the necessary prenylation (lipid modification) of small guanosine triphosphate (GTP)-binding proteins, which are critical for signaling pathways that govern cell function. This blockade disrupts the cytoskeletal integrity and adhesion properties of the osteoclast, leading to the loss of the ruffled border and the eventual induction of apoptosis (programmed cell death). The resulting reduction in the number and activity of bone-resorbing osteoclasts modulates the balance between bone resorption and bone formation, allowing for unopposed osteoblast activity and a reduction in systemic bone turnover markers.

Dosage and Administration Information

How to Use Zorendol: Official Administration Guidelines

Zorendol (Ibuprofen) is used according to specific protocols governing administration, dosing, and duration. The medicine is most commonly delivered via the oral route in forms such as tablets, capsules, or suspensions, although the intravenous (IV) route is reserved for administration in specific clinical settings.


Administration Scope and Dosing

Category Official Administration Guidelines
Route of administration Oral (most common) and Intravenous (IV) infusion.
Dosing schedule OTC Use: Typically 200 mg to 400 mg per dose. Prescription Use: Up to 800 mg per dose, with a maximum daily intake of 3,200 mg in divided doses for specific conditions.
Timing in relation to meals May be taken with food or milk to potentially mitigate gastric discomfort, or on an empty stomach for faster absorption.
Frequency pattern Doses are administered as needed, typically every 4 to 6 hours, with a mandated minimum interval of at least four hours between administrations.

The overarching treatment principle is to utilize the lowest effective dosage for the shortest duration necessary to manage symptoms. For over-the-counter use, self-treatment is often limited to a maximum of 10 days for pain or 3 days for fever. Special consideration is required for specific populations; older adults, for example, are directed to use the lowest dose for the shortest period, and dose adjustment or avoidance is required in cases of severe renal or hepatic impairment.

Recent Clinical Evidence

Zorendol (also known by its generic name, zuranolone) is a neuroactive steroid compound that is classified as a positive allosteric modulator of the gamma-aminobutyric acid type A ( GABAA) receptor. Clinical evidence has primarily focused on its use for depressive disorders.

Recent regulatory approval for Zorendol was based on data from the NEST clinical development program, which included two pivotal Phase 3 randomized, double-blind, placebo-controlled studies (ROBIN and SKYLARK) in adult women with postpartum depression (PPD).


Key Clinical Findings (Postpartum Depression)

In both the ROBIN and SKYLARK studies, Zorendol was associated with a statistically significant mean reduction from baseline in the 17-item Hamilton Rating Scale for Depression (HAMD-17) total score, a common measure of depression severity, at the primary endpoint (Day 15) compared to the placebo group.

  • Onset of Reduction: In the SKYLARK study, which evaluated the 50 mg dose, reduction in depressive symptoms was observed as early as Day 3 and was sustained through Day 45 of the follow-up period.
  • Efficacy Measure: The statistically significant difference in the mean change from baseline in the HAMD-17 total score between the Zorendol group and the placebo group was the primary measure of benefit.

Tolerability Profile

Across the clinical development program, Zorendol was reported to be generally well-tolerated. The most frequently observed side effects (incidence 5% and greater than placebo) included somnolence (drowsiness), dizziness, diarrhea, fatigue, and urinary tract infection. Study participants were monitored, and the drug’s course of treatment was limited to 14 days.

Key Studies & References

  1. Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression: The LANDSCAPE and NEST Development Program (Overview)

Frequently Asked Questions (FAQ)

Common questions about Zorendol (FAQ)

Q: How do I know if Zorendol is working as intended?

Studies and official information indicate that Zorendol's effectiveness is measured by observed changes in clinical assessment scores, such as the reduction in the HAMD-17 total score for Postpartum Depression. For Zorendol (Ibuprofen), efficacy is related to objective measures like reduced pain and fever. Symptom improvements are consistent with the intended therapeutic effect of the medication.

Q: Does Zorendol treat the underlying condition or primarily manage symptoms?

Regulatory documents classify Zorendol (Ibuprofen) as an analgesic, antipyretic, and anti-inflammatory agent. This means its mechanism works to provide relief by managing symptoms like pain, fever, and inflammation, typically through the inhibition of prostaglandin synthesis.

Q: What are the typical signs of a potential allergic reaction to Zorendol?

According to official product information, signs of a potential allergic reaction or hypersensitivity include skin rash or hives (urticaria). More serious signs can involve swelling of the face or throat (angioedema), or difficulty breathing and wheezing. Symptoms consistent with a severe reaction are noted as requiring urgent medical attention.

Q: What is the difference between a common side effect and an emergency adverse event for Zorendol?

Official labeling makes a distinction between common, generally less severe reactions and rare but serious adverse events. Common side effects are frequently reported in trials, such as headache or upset stomach. Serious adverse events, like signs of severe gastrointestinal bleeding or stroke, are rare and are noted in the labeling as requiring urgent medical evaluation.

Q: Are there specific antibiotics or antifungals that are known to interact with Zorendol?

Official product information addresses the need for dosage evaluation or avoidance if Zorendol is taken with strong CYP3A4 inhibitors or inducers. These enzyme-affecting drug classes include certain antibiotics and antifungals, as they may change the levels of Zorendol in the body.

Q: What is an 'interaction' in the context of taking Zorendol with other substances?

Regulatory resources define a drug interaction as a change in how a substance is processed by the body when combined with another. This change can alter Zorendol's intended effect, either by increasing the risk of side effects or by reducing its effectiveness.

Q: Is Zorendol a generic drug or a brand-name drug?

Zorendol is a proprietary brand name that may refer to two different active ingredients, depending on the indication. When used for pain or fever, its active component is the generic drug Ibuprofen. When used for Postpartum Depression, the active component is Zuranolone, which is also referenced by its generic name.

Q: Can Zorendol cause dependence or withdrawal symptoms?

Regulatory labeling states that Zorendol is not classified as a controlled substance. Specifically, the official product information for Zuranolone indicates that studies found no signs or symptoms consistent with physical dependence or withdrawal after the drug was rapidly stopped.

Q: Is it possible to take Zorendol and experience no side effects?

Based on official frequency data from clinical studies, while side effects are possible, they are not guaranteed. Official data indicates that experiencing side effects is not guaranteed, as not all participants in studies reported them.

Q: Does taking Zorendol affect routine lab test results?

Official labeling notes that Zorendol (Ibuprofen) may affect certain laboratory measurements. The labeling notes that Zorendol may interfere with certain laboratory measurements, including some liver, kidney function, and blood coagulation tests.

Q: Does Zorendol affect mood or cause any psychological side effects?

Official safety data includes reported mental health-related adverse reactions for both components. Zorendol (Ibuprofen) lists nervousness, and Zorendol (Zuranolone) labeling includes psychiatric disorders, which have included reports related to changes in mood and suicidal ideation or behavior.

Q: Are the initial side effects of Zorendol generally temporary?

Official documents note that some adverse effects are reported with greater frequency during the initial phase of treatment. This contrasts with the known risks associated with long-term exposure, but official sources do not provide explicit timelines for the resolution of these initial effects.

Q: Can Zorendol be associated with changes in body weight?

Official safety documentation for Zorendol (Zuranolone) reported both weight gain and weight decrease in clinical trials. These changes in body weight were among the reported adverse reactions.

Q: Are there specific herbal supplements that should be avoided while on Zorendol?

Official sources advise caution with all supplements due to the potential for interactions. Official sources highlight a need for review, especially with herbal supplements known to affect bleeding risk or the central nervous system (CNS).

Q: Does consumption of grapefruit or grapefruit juice affect Zorendol?

Grapefruit is recognized as a strong inhibitor of the enzyme CYP3A4, which is involved in processing Zorendol in the body. Official labeling addresses the need for adjustment or avoidance when Zorendol is taken with strong CYP3A4 inhibitors.

Q: Can Zorendol be taken with common vitamins like Vitamin D or B12?

Official warnings focus on interactions with prescription medicines and supplements that affect bleeding or metabolism. Regulatory documents primarily focus on interactions with prescription medicines and supplements that affect bleeding or metabolism.

Q: Does Zorendol interact with any supplements commonly used for sleep?

Official documents warn about co-administration with other medications that cause sedation, which may include some sleep aids or supplements. This is due to the potential for additive central nervous system (CNS) depressant effects from Zorendol.

Q: Can Zorendol affect the effectiveness of oral contraceptives (birth control pills)?

Official labeling for Zorendol (Ibuprofen) notes that NSAIDs may diminish the effects of intrauterine devices (IUDs). The Zuranolone label notes that effective contraception is required during treatment and for a period afterward.

Q: Does Zorendol interact with medications used for diabetes management?

Official labeling for Zorendol (Ibuprofen) notes that NSAIDs can interact with a class of diabetes medications known as Sulphonylureas. Reports indicate that this combination may be associated with an increased risk of low blood sugar (hypoglycemia).

Q: Is Zorendol a possible treatment option for children or adolescents?

The official use of Zorendol depends on the active ingredient. Zorendol (Ibuprofen) is indicated for use in children to treat fever and pain. However, Zorendol (Zuranolone) is explicitly indicated only for use in adults with Postpartum Depression.

Q: Can Zorendol be used safely while breastfeeding?

Official documents indicate that Zorendol (Ibuprofen) is generally considered compatible with breastfeeding. However, Zorendol (Zuranolone) labeling notes that caution is advised, as there is a potential for the medication to pass into breast milk.

Q: Are there differences in the effectiveness or side effects of Zorendol reported for men versus women?

Clinical trials for Zorendol (Zuranolone) focused exclusively on adult women with Postpartum Depression. General use data for Zorendol (Ibuprofen) is not officially differentiated by sex in the consumer label, although risks for different populations are noted.

Q: Is Zorendol still being monitored or studied by regulators after its initial approval?

Regulatory documents confirm that Zorendol is subject to continuous monitoring after its approval through post-marketing safety reporting. This ongoing monitoring may involve specific programs put in place to manage known risks.

Q: Is there a risk of becoming tolerant to the effects of Zorendol over time?

Official regulatory text states that Zorendol is not classified as a controlled substance. Clinical studies indicated no reports of tolerance developing to the effects of Zorendol (Zuranolone).

Q: What are the reported effects if Zorendol is suddenly stopped?

According to official labeling for Zorendol (Zuranolone), rapid discontinuation of the medication did not show signs or symptoms consistent with withdrawal in clinical studies.

How should Zorendol be stored and disposed of?

How to Store and Dispose of Zorendol?


Official Storage and Stability Requirements

Labeled Storage Conditions: Zorendol must be stored at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). The product must be protected from moisture and light by remaining in its original container. It is critical to not freeze Zorendol.

Packaging and Child Safety: Keep the medicine in its original, tightly closed container and out of the sight and reach of children and pets. Adhere to any specified in-use stability periods, such as discarding the product within a certain number of days after reconstitution or opening.


Official Disposal Rules

Disposal Method: The preferred method for discarding expired or unused Zorendol is through an authorized drug take-back program. If a take-back option is unavailable and the medicine is not on a special government Flush List, it should be mixed with an undesirable substance (e.g., cat litter) and sealed in a container before being placed in household trash, to prevent misuse or environmental release.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zorendol found in:

A-Z Index: